Wingtech Technology establishes independent management for Nexperia's Chinese unit, ensuring operational autonomy amid a dispute with Nexperia's Dutch headquarters over control and operations.
Shenzhen-based Wingtech has sued in a Guangdong court, demanding restoration of control over Nexperia and 8 billion yuan in compensation, after the Dutch government's September 2025 order to seize control was suspended but left Wingtech's control "restricted".
Wingtech Technology faces a delisting risk warning on the Shanghai Stock Exchange after its auditor issued a disclaimer of opinion regarding Nexperia's financial records. The company has until the end of 2026 to resolve the audit issues.
